Id |
Subject |
Object |
Predicate |
Lexical cue |
T208 |
6-10 |
IN |
denotes |
with |
T209 |
11-19 |
NN |
denotes |
severity |
T210 |
19-20 |
-COMMA- |
denotes |
, |
T211 |
21-32 |
NN |
denotes |
criticality |
T212 |
32-33 |
-COMMA- |
denotes |
, |
T213 |
34-39 |
JJ |
denotes |
viral |
T214 |
40-44 |
NN |
denotes |
load |
T215 |
44-45 |
-COMMA- |
denotes |
, |
T216 |
46-49 |
CC |
denotes |
and |
T217 |
50-59 |
NN |
denotes |
prognosis |
T218 |
60-62 |
IN |
denotes |
of |
T219 |
63-71 |
NNS |
denotes |
patients |
T220 |
72-76 |
IN |
denotes |
with |
T221 |
77-85 |
NN |
denotes |
COVID-19 |
T222 |
87-98 |
NNP |
denotes |
Tocilizumab |
T223 |
98-99 |
-COMMA- |
denotes |
, |
T224 |
100-101 |
DT |
denotes |
a |
T225 |
102-112 |
JJ |
denotes |
monoclonal |
T226 |
113-121 |
NN |
denotes |
antibody |
T227 |
122-129 |
IN |
denotes |
against |
T228 |
130-133 |
NN |
denotes |
IL6 |
T229 |
133-134 |
-COMMA- |
denotes |
, |
T230 |
135-140 |
MD |
denotes |
could |
T231 |
141-147 |
VB |
denotes |
confer |
T232 |
148-156 |
JJ |
denotes |
clinical |
T233 |
157-164 |
NN |
denotes |
benefit |
T234 |
165-167 |
IN |
denotes |
in |
R200 |
T209 |
T208 |
arg2Of |
severity,with |
R201 |
T209 |
T210 |
arg1Of |
severity,"," |
R202 |
T211 |
T210 |
arg2Of |
criticality,"," |
R204 |
T214 |
T212 |
arg2Of |
load,"," |
R205 |
T214 |
T213 |
arg1Of |
load,viral |
R206 |
T216 |
T215 |
arg1Of |
and,"," |
R207 |
T212 |
T216 |
arg1Of |
",",and |
R208 |
T217 |
T216 |
arg2Of |
prognosis,and |
R209 |
T217 |
T218 |
arg1Of |
prognosis,of |
R210 |
T219 |
T218 |
arg2Of |
patients,of |
R211 |
T219 |
T220 |
arg1Of |
patients,with |
R212 |
T221 |
T220 |
arg2Of |
COVID-19,with |
R213 |
T222 |
T223 |
arg1Of |
Tocilizumab,"," |
R214 |
T226 |
T223 |
arg2Of |
antibody,"," |
R215 |
T226 |
T224 |
arg1Of |
antibody,a |
R216 |
T226 |
T225 |
arg1Of |
antibody,monoclonal |
R217 |
T226 |
T227 |
arg1Of |
antibody,against |
R218 |
T228 |
T227 |
arg2Of |
IL6,against |
R219 |
T231 |
T229 |
arg1Of |
confer,"," |
R220 |
T222 |
T230 |
arg1Of |
Tocilizumab,could |
R221 |
T231 |
T230 |
arg2Of |
confer,could |
R222 |
T222 |
T231 |
arg1Of |
Tocilizumab,confer |
R223 |
T233 |
T231 |
arg2Of |
benefit,confer |
R224 |
T233 |
T232 |
arg1Of |
benefit,clinical |
R225 |
T231 |
T234 |
arg1Of |
confer,in |